Diversified Healthcare Trust
NASDAQ:DHCREIT - Healthcare Facilities
+$0.25 today
- Market cap
- $1.76B
- Beta
- 2.29
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$1.33
- Dividend yield
- 0.45%
Volume 1.69M
Average 1.79M
DHC Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Diversified Healthcare TrustNASDAQ: DHC
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income growth accelerates
Q1 FY2026 net income of $43.28M (cash outflow) rose 381.6% year over year, ahead of the +9.3% change in trailing-twelve-month net income. Sequentially, it rose 103.9% from the prior quarter. Over 3 fiscal years it compounded at +162.7% a year.
Context
- Net income amounted to 18.6% of revenue in FY2025, down 6.2 pp from a year earlier.
- Net income grew in size in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 3 analysts of -$158.95M (-44.4%) for the fiscal year ending Dec 2026, a slowdown from the -22.8% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$43.28M+103.9% QoQ
- Last fiscal yearDec 2025
- -$285.89M-22.8% YoY
- LTMMar 2026
- -$320.18M+9.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +381.6% | -61.4% | -443.0 pp |
| 1 year | -22.8% | -44.4% | -21.6 pp |
| 3-year CAGR | +162.7% | -31.7% | -194.4 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (285.89M) USD
- Year-over-year change
- +22.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (285.89M) | +22.8% |
| FY2024 | 2024-12-31 | (370.26M) | -26.1% |
| FY2023 | 2023-12-31 | (293.57M) | -1761.1% |
| FY2022 | 2022-12-31 | (15.77M) | -108.8% |
| FY2021 | 2021-12-31 | 179.93M | — |
Net Income vs competitors
How DHC compares with its peers on the latest reported figures
- DHC's LTM Mar 2026 net income of $320.18M is the 2nd largest of the 7 companies compared; the peer median is $67.61M.
- Its year-over-year change of +9.3% is the 6th highest of 7, against a peer median of +44.0%.
- Net income amounts to 21.1% of revenue for DHC, versus a peer median of 15.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $562.92M | +47.2% | +229.8% | 69.1% | |
| LTM Mar 2026 | $320.18M | +9.3% | +162.7% | 21.1% | |
| LTM Mar 2026 | $142.81M | +16.8% | — | 10.2% | |
| LTM Mar 2026 | $134.31M | -2.1% | — | 18.8% | |
| LTM Mar 2026 | $123.06M | +692.6% | — | 16.1% | |
| LTM Mar 2026 | $86.42M | +40.7% | — | 15.3% | |
| LTM Mar 2026 | $12.17M | +193.2% | -48.5% | 4.5% | |
| Peer median (excluding DHC) | $67.61M | +44.0% | +90.6% | 15.7% | |
Competitors are the stored peer set for DHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 179.93M | (15.77M) | (293.57M) | (370.26M) | (285.89M) |
| Depreciation & Amortization | 263.92M | 239.53M | 283.84M | 285.06M | 262.04M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (65.12M) | 1.64M | (27.84M) | 6.82M | 33.26M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (65.12M) | 1.64M | (27.84M) | 6.82M | 33.26M |
| Other Non-Cash Items | (442.05M) | (265.74M) | 48.05M | 190.6M | (29.03M) |
| Operating Cash Flow | (63.32M) | (40.35M) | 10.48M | 112.22M | (19.62M) |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 367.03M | 108.42M | 0 | (21.18M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (124.34M) | 279.28M | (202.11M) | (165.84M) | 483.57M |
| Investing Cash Flow | 242.7M | 387.71M | (202.11M) | (187.02M) | 483.57M |
| Debt Repayment | 789.34M | (639.07M) | (217.05M) | (3.22M) | (443.54M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (383K) | (171K) | (393K) | (904K) | (1.15M) |
| Dividends Paid | (9.54M) | (9.57M) | (9.6M) | (9.63M) | (9.66M) |
| Other Financing Activities | (32.7M) | (27.19M) | (22.68M) | (8.56M) | (37.66M) |
| Financing Cash Flow | 746.72M | (676M) | (249.71M) | (22.31M) | (492.01M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 926.1M | (328.64M) | (441.34M) | (97.11M) | (28.06M) |
| Free Cash Flow | (63.32M) | (40.35M) | 10.48M | 112.22M | (19.62M) |
Diversified Healthcare Trust
NASDAQ:DHC
Intrinsic Alpha fair value
Locked
Current Price
$7.24
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.